MedTrace Logo

Screening, Treatment, and Eradication of Hep C

NCT05071261 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 112136

Last updated 2024-08-27

No results posted yet for this study

Summary

The aim of this study is to assess the HCV screening rate in Arizona by identification of potential HCV patients/subjects through different methods of communication - text message, email, social media, radio, newspaper ads, and flyers.

Conditions

  • Hepatitis C Virus Infection

Interventions

DIAGNOSTIC_TEST

Hepatitis C Virus Screening

1-2 Blood Screenings for Hepatitis C Virus

Sponsors & Collaborators

  • Liver Institute PLLC

    lead OTHER

Principal Investigators

  • Huma Habib, MBA · Director

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2030-10-01
Completion
2030-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05071261 on ClinicalTrials.gov